semaglutide and suicidal ideation associated with lower risk of ideations compared to other treatments prescribed for obesity or type 2 diabetes Weight loss: Using drugs like

Specific situations requiring medical advice include: consistently elevated blood pressure readings above 140/90 mmHg (or above the individual target set by their healthcare team), symptoms suggesting low blood pressure such as recurrent dizziness or fainting, or any new cardiovascular symptoms including chest pain, palpitations, or unusual shortness of breath

it is not approved for weight loss. It is addressed in the Zepbound label because it is may be an adverse reaction potentially related to weight reduction, the spokesperson said

The main ones are semaglutide (Ozempic, Rybelsus, Wegovy), tirzepatide (Mounjaro, Zepbound, which also activates the GIP receptor), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and exenatide (Byetta, Bydureon)

Early Follow-up: Around 6-8 weeks after starting, to see how your body is reacting

Wang G, Zhang L, Zhang S et al (2023) The combined use of a plant growth promoting Bacillus sp